Pearl River Capital, LLC Biogen Inc. Transaction History

Pearl River Capital, LLC

$0
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $1.61 Million - $2.04 Million	7,605 New	7,605 $1.64 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $348,540 - $393,384	1,376 Added 50.55%	4,098 $1.05 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $379,294 - $438,286	-1,378 Reduced 33.61%	2,722 $775,000
Q1 2023 Dec 19, 2024	BUY	$256.56 - $292.34 $1.05 Million - $1.2 Million	4,100 New	4,100 $1.14 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $1.66 Million - $1.89 Million	-6,454 Reduced 61.15%	4,100 $1.14 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $381,689 - $463,760	1,512 Added 16.72%	10,554 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $964,494 - $1.33 Million	-4,954 Reduced 35.4%	9,042 $2.41 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $266,681 - $317,134	1,422 Added 11.31%	13,996 $2.85 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $2.44 Million - $3.07 Million	12,574 New	12,574 $2.65 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $831,638 - $1.07 Million	-3,714 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $357,133 - $465,741	1,262 Added 51.47%	3,714 $1.05 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $734,524 - $1.18 Million	-2,836 Reduced 53.63%	2,452 $849,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.28 Million - $1.51 Million	5,288 New	5,288 $1.48 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $2.52 Million - $2.91 Million	-9,509 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $1.31 Million - $1.73 Million	5,060 Added 113.73%	9,509 $2.54 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $979,046 - $1.35 Million	4,449 New	4,449 $1.32 Million

Others Institutions Holding BIIB

# of Institutions

993

Shares Held

130M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Account